Semaglutide may be the right starting point if you: Are new to GLP-1 therapy and want to start with the most established option Have a moderate amount of weight to lose Don't have significant insulin resistance or type 2 diabetes Want a well-documented safety profile with years of real-world data Tirzepatide may be the stronger option if you: Have a higher BMI or significant amount of weight to lose Have insulin resistance, prediabetes, or type 2 diabetes Have tried Semaglutide previously with limited results Want the most aggressive metabolic intervention currently available Are dealing with significant visceral fat or metabolic syndrome The Most Important Factor: Medical Guidance The right medication is the one your provider determines is appropriate for your health history, labs, BMI, and goals not the one that sounds more advanced or that someone else is using

The resulting state of imbalance, known as oxidative stress, results in free radicals targeting cellular organelles, damaging lipids, nucleic acids, and proteins
However, the lack of generic options within the GLP-1 receptor agonist class presents a unique challenge for diabetes care teams
She is an international speaker who trains other licensed medical providers, including MDs, on the prescription and clinical management of HRT
Storage requirements Temperature: Store at controlled room temperature, 68-77F (20-25C)
Referenced Citations Adipose Tissue-Derived Stem Cell Secreted IGF-1 Protects Myoblasts from the Negative Effect of Myostatin. [Online]